NASDAQ now offers some unusual shares: Tilray, a global leader in medical cannabis research, cultivation, processing, and distribution, launched the first IPO in this sphere. Tilray is offering 9 million shares of Class 2 at the opening price of $23,05 per share. The company intends to grant underwriters a 30-day over-allotment option to purchase up to 1,350,000 of additional shares.
The ticker of the share is NASDAQ:TLRY and it’s already available in the default list of the stock section in EXANTE Trading Platform.
Tilray is the first GMP-certified medical cannabis producer to supply cannabis products to tens of thousands of patients, physicians, pharmacies, hospitals, and researchers. With its branches located in Europe, USA and Canada, it operates all over the world from Chile to New Zealand.
The information in this text is provided to you for informational purposes only and should not be regarded as an offer or solicitation of an offer to buy or sell any investments or related services that may be referenced here.